Ligand selectivity for the acetylcholine binding site of the rat α4β2 and α3β4 nicotinic subtypes investigated by molecular docking

被引:22
作者
Bisson, WH
Scapozza, L
Westera, G [1 ]
Mu, LJ
Schubiger, PA
机构
[1] Paul Scherrer Inst, Swiss Fed Inst Technol Zurich, Ctr Radiopharmaceut Sci, Villigen, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
关键词
D O I
10.1021/jm040881a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The homology models of the extracellular domains of the neuronal alpha 4 beta 2 (pdb code: 1ole) and ganglionic alpha 3 beta 4 (pdb code: 1olf) rat nicotinic acetylcholine receptor (nAChR) subtypes were refined and energetically minimized. In this work, a series of nAChR ligands (1 - 15) were docked into the modeled binding cavity of both receptors. High-affinity, toxic ligands such as epibatidine (1) and dechloroepibatidine (2) docked into cluster 1 with the charged tertiary amino group, forming a pi-cation interaction with Trp 147 on the (+) side of the alpha 4 subunit and establishing a characteristic H-bond with the Lys 77 on the H side of the beta 2 subunit. The nontoxic ligands such as 33bMet (3), (S)-A-85380 (4), and acetylcholine (6) docked into cluster 2 with the same.,pi-cation interaction but with the rest of the molecule occupying a different moiety of the binding pocket. Molecular docking into the alpha 3 beta 4 subtype showed that both enantiomers of 1 (1a and 1b) are representative templates for ligands with affinity toward this ganglionic nAChR subtype. The ranking scores of the docked molecules confirm the existence of structure-dependent subtype selectivity and shed light on the design of specific and selective alpha 4 beta 2 nAChR subtype ligands.
引用
收藏
页码:5123 / 5130
页数:8
相关论文
共 36 条
[1]   Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors [J].
Abreo, MA ;
Lin, NH ;
Garvey, DS ;
Gunn, DE ;
Hettinger, AM ;
Wasicak, JT ;
Pavlik, PA ;
Martin, YC ;
DonnellyRoberts, DL ;
Anderson, DJ ;
Sullivan, JP ;
Williams, M ;
Americ, SP ;
Holladay, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :817-825
[2]  
BADIO B, 1994, MOL PHARMACOL, V45, P563
[3]   Cation-π interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors:: The anomalous binding properties of nicotine [J].
Beene, DL ;
Brandt, GS ;
Zhong, WG ;
Zacharias, NM ;
Lester, HA ;
Dougherty, DA .
BIOCHEMISTRY, 2002, 41 (32) :10262-10269
[4]   Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations [J].
Bissantz, C ;
Folkers, G ;
Rognan, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4759-4767
[5]   Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors [J].
Brejc, K ;
van Dijk, WJ ;
Klaassen, RV ;
Schuurmans, M ;
van der Oost, J ;
Smit, AB ;
Sixma, TK .
NATURE, 2001, 411 (6835) :269-276
[6]   Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures [J].
Celie, PHN ;
van Rossum-Fikkert, SE ;
van Dijk, WJ ;
Brejc, K ;
Smit, AB ;
Sixma, TK .
NEURON, 2004, 41 (06) :907-914
[7]   Allosteric receptors after 30 years [J].
Changeux, JP ;
Edelstein, SJ .
NEURON, 1998, 21 (05) :959-980
[8]   A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES [J].
CORNELL, WD ;
CIEPLAK, P ;
BAYLY, CI ;
GOULD, IR ;
MERZ, KM ;
FERGUSON, DM ;
SPELLMEYER, DC ;
FOX, T ;
CALDWELL, JW ;
KOLLMAN, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5179-5197
[9]   A structural model of agonist binding to the α3β4 neuronal nicotinic receptor [J].
Costa, V ;
Nistri, A ;
Cavalli, A ;
Carloni, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (05) :921-931
[10]  
Dart M J, 2000, Pharm Acta Helv, V74, P115, DOI 10.1016/S0031-6865(99)00023-0